Event on
Etiological confirmation of acute respiratory infections using POC testing for Covid-19 and influenza and the impact of antimicrobial resistance
演示文稿
-
AMILCAR TANURI, MD, PHD
(BRAZIL)
SpeakerMOLECULAR VIROLOGIST UNIVERSITY OF RIO DE JANEIRO.
-
PROF. MANAF ALQAHTANI, MD
(BAHRAIN)
SpeakerROYAL COLLEGE OF SURGEONS IN IRELAND (RCSI) SENIOR CONSULTANT INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGIST HEAD OF MICROBIOLOGY LAB AND INFECTION CONTROL DEPARTMENT BAHRAIN DEFENCE FORCE (BDF) HOSPITAL.
WHAT WE KNOW ABOUT COVID-19 AND INFLUENZA (2020-2022): AN EVOLVING EPEDEMIC IN A PANDEMIC
-
PROF. HAFIX AHMAD, PHD
(UNITED ARAB EMIRATES)
Speaker(CO-CHAIR: UAE NATIONAL ANTIMICROBIAL STEWARDSHIP COMMITTEE) ASSOCIATE PROFESSOR & CLINICAL MICROBIOLOGIST DEPARTMENT OF MEDICAL MICROBIOLOGY AND IMMUNOLOGY RAK COLLEGE OF MEDICAL SCIENCES, RAK MEDICAL & HEALTH SCIENCES UNIVERSITYHEAD OF MICROBIOLOGY & MOLECULAR DIVISION- NGS & COVID LAB IN-CHARGE, RAK HOSPITAL.
ANTIMICROBIAL STEWARDSHIP USING MOLECULAR & POC TESTING FOR RESPIRATORY PATHOGENS
-
ROGIER HOPSTAKEN, MD, PHD
(NETHERLANDS)
SpeakerGENERAL PRACTITIONER GP PRACTICE HAPERT AND HOOGELOON MAASTRICHT UNIVERSITY.
所提出的观点和意见仅代表作者。 此网络广播中包含的内容仅供参考/教育目的。
背景
Healthcare professionals are encouraged to watch this clinical and scientific recording from the Medlab Middle East 2023 Conference for updates on the use of Point of Care diagnostics for COVID-19 and Influenza testing in decentralized settings. Investigators and clinical experts will share their research and practical experience with point of care testing. The availability of timely results and its impact on patient management and antimicrobial resistance prevention.
- Discuss the importance of an early differential diagnosis of COVID-19 and Influenza
- Share study and practical experience with POC testing
- Explore the evidence describing the impact of an early and accurate diagnosis on infection control and antibiotic resistance prevention
© 2024 年雅培。版权所有。引用的所有商标均为雅培集团公司或其各自所有者的商标。 COL-00000